𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia

✍ Scribed by Miyachi, Hayato; Tanaka, Yumiko; Gondo, Kazumi; Kawada, Tsutomu; Kato, Shunichi; Sasao, Tamotsu; Hotta, Tomomitsu; Oshima, Shuichi; Ando, Yasuhiko


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
233 KB
Volume
62
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Specific expression of different CD45 isoforms can be seen in various stages of differentiation of normal nucleated hematopoietic cells. Association of membrane expression

of CD45 isoforms and differential levels of leukemia cells was studied in 91 cases with de novo acute myeloid leukemia (AML). Membrane expression of CD45RA and CD45RO was analyzed by flow cytometry and their expression patterns were compared with AML subtypes classified according to the French-American-British (FAB) classification. CD45RA was essentially expressed in all of the FAB myelocytic subtypes (M0-M3). Its expression in percentage was lower in the most differentiated subtype of AML (M3) when compared with other myelocytic subtypes. CD45RO expression was rarely observed in cases with myelocytic subtypes (1/56 cases of M0, M1, M2, and M3) except for the minimally differentiated myelocytic subtype (M0) or those with potential for differentiation to T-cell lineage where three of 12 cases showed CD45RO expression. When leukemia cells of an M3 case were differentiated to mature granulocytes by treatment of all-trans-retinoic acid, they showed increasing expression of CD45RO. In subtypes with a monocytic component (M4 and M5), both of CD45RA and CD45RO expression were observed and mutually exclusive. When 10 cases of M5 were subdivided by the differential level into undifferentiated (M5a) and differentiated monocytic leukemia (M5b), expression of CD45RA and CD45RO was strictly restricted to cases with M5a and M5b, respectively. These results suggest that CD45 isoform expression in AML characterizes differential levels both in myelocytic and monocytic lineages and specifically disturbed in each subtype. The assessment of CD45 isoform expression appears to provide an insight on biological characteristics and a useful supplementary test for differential diagnosis of AML subtypes. Am.


πŸ“œ SIMILAR VOLUMES


Biologic and clinical significance of CD
✍ Saxena, Anurag; Sheridan, David P.; Card, Robert T.; McPeek, A.M.; Mewdell, C.C. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 1 views

CD7 antigen, a T-cell lineage associated antigen, is expressed in a minority of patients with acute myeloid leukemia (AML). The biologic and clinical significance of this finding is not clearly established. In this retrospective study of patients with de novo acute myeloid leukemia, we have identifi

Altered intracellular distribution of da
✍ Dominique Lautier; Jean-Denis Bailly; CΓ©cile Demur; Jean-Marc Herbert; Christine πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 224 KB πŸ‘ 1 views

We have used laser-assisted confocal microscopy to evaluate the intracellular distribution of daunorubicin (DNR) in acute myeloid leukemia (AML) cell lines and fresh AML cells according to their differentiation phenotype. In KG1a, KG1, TF-1 and HEL cells, which express the early differentiation mark

Aberrant CD2 expression in precursor-B a
✍ Dunphy, Cherie H.; Chu, Jen-Yih πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 1 views

Aberrant CD2 expression in childhood precursor-B ALL is rare and has recently been reported with an incidence of 3.6% in a study by Cantu-Rajnoldi et al. [Haematologica 77:384, 19921. There was no association of the CD2 co-expression with other known prognostic factors. Our study represents the seco

Expression of exon v6-containing CD44 is
✍ Akira Yokota; Genichiro Ishii; Yoshiki Sugaya; Miki Nishimura; Yasushi Saito; Ke πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 1 views

CD44 is a cell surface glycoprotein with a number of isoforms generated by alternative splicing of ten 'variant' exons in humans. Variant exon 6-containing isoforms of CD44 (CD44v6) have been implicated in the metastatic potential of rat carcinoma cell lines. Human homologues of CD44v6 are expressed